About Index Trending news
Analyze
Pricing
KaloBios Pharmaceuticals, Inc.

KaloBios Pharmaceuticals, Inc.

KaloBios Pharmaceuticals, Inc.

KaloBios is a biopharmaceutical company dedicated to helping the lives of patients with innovative therapies.

Elsewhere

Alexa global traffic share

Latest funding
Post-IPO equity
$12,150,000
Post-IPO debt
$3,000,000
Employees

Team size

10+
Locations
HQ
Headquarters
$3,000,000 Post-IPO debt
FierceBiotech

KaloBios emerges from bankruptcy, raises $14M in recap

Health Strategy